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Abstract
Our main aim is to make a contribution to the establishment of sources of oxidants as the key factors in understanding the role that oxidants and oxidative stress play 
in the pathogenesis of neurodegeneration, i.e. in the progression of Alzheimer’s disease (AD). Our original observation pointed out the main difference between the 
hemoglobin and methemoglobin degradation, did from the heme oxygenation when a hemoglobin results in ferrous (Fe2+) iron, but methemoglobin catabolism 
produces ferric (Fe3+) iron. The methemoglobin plays a role of the carrier, the donor of cytotoxic and redox-active ferric (Fe3+) iron, and it also acts as the originator 
of neurodegenerative diseases. The abundant and permanent source of redox-active ferric (Fe3+) iron which, without Ferrous-Ferric inversions, has “in situ” direct 
impact on endothelial small vessels in the brain accumulates and increases the rate of capillary endothelial cell apoptosis and possibly crosses into brain parenchyma to 
the astrocytes, glia, neurons, and other neuronal cells. Our understanding of the transport and neuronal accumulation of ferric (Fe3+) iron points to how microvessels 
are organized into a well-structured neurovascular unit with harmful consequences to the brain. Our previously conducted research found that the neonatal jaundice 
incidence (p=0.034), heart murmur at a later age (p=0.011) and mild disorders in children and adults such as dyslalia and learning/memory impairments (p=0.002) 
were significantly higher than in children and adults of control mothers without pregnancy methemoglobinemia.
The consequence are performed as initial brain iron harmful effects from the mother-fetal pregnancy methemoglobinemia complication, and according to our 
hypothesis in humans could be followed with the neuronal death, the disease aging process, and leading finally to the severe  disorders as AD, PD and other 
neurodegenerative diseases.
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Introduction
It is still not known why iron levels are abnormally high in some 
regions of the brain in neurodegenerative disorders and it is also not 
clear whether iron accumulation in the brain is the initial event that 
causes neuronal death or is a consequence of the disease process. 
According to the previous research, we consider that, at least in some 
neurodegenerative disorders, brain iron misregulation is the initial 
cause of neuronal death and that this misregulation might be the linked 
to either genetic or non-genetic factors.
Ferric-iron brain accumulation as a cause of 
neurodegenerative brain disease: A new insight to 
understanding the mechanism of iron transport
Our research focused on people who continuously inhale strong 
oxidants such as NOx (NO andNO2) and it showed that these oxidants 
can reversibly oxidize oxyhemoglobin (Fe2+) to methemoglobin 
(Fe3+). Irreversible methemoglobinemia can occur because of the 
disruption of the oxidant/antioxidant balance, supported by the 
synergic SO2 metabolites, leading to the degradation of antioxidant 
thiols [1]. Methemoglobin by itself and heme have prooxidant 
properties and induce structural and functional changes in the 
vascular endothelium [2,3]. These changes include cell growth arrest, 
senescence, morphological alterations and cell apoptosis, and they 
lead to both vessel trombosis and endothelial cell denudation under 
the influence of redox-active ferric iron (Fe3+), which is a product of 
heme-oxygenase, responsible for methemoglobin-heme degradation 
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[4]. In the blood, Nitric oxide and Superoxide form Peroxinitrites 
(ONOO), that convert oxyhemoglobin into methemoglobin, and the 
methemoglobin released from heme induces endothelial cytolysis [5]. 
The toxicity of H2O2 is also dependent upon its reaction with ferrous 
iron to form hydroxyl radicals by the Fenton reaction. The ferrous iron 
needed for this reaction is formed by the reduction of cellular ferric 
iron by superoxide ions [6]. We would like to emphasize the difference 
between physiological hemoglobin catabolism and pathological 
methemoglobin catabolism, because their different final products, 
ferrous and ferric iron, have distinct characteristics. Ferrous iron has 
the potential for catalyzing and generating highly cytotoxic hydroxyl 
radicals as the Fenton reactions (ferrous iron + H2O2 ---> ferric iron + 
OH + OH). Ferric iron is then reduced back to ferrous iron, peroxide 
radical and proton by the same hydrogen peroxide. 
The substantial difference between the intracellular ferric iron 
originates from Fenton reaction, and ferric iron originates from 
methemoglobin catabolism influence a level of methemoglobin cellular 
uptake which increases the methemoglobinemia leading to ferric-iron-
induced oxidative stress injury. 
We consider that during methemoglobin catabolism, the final 
ferric iron product is a significantly added source of ferric iron derived 
from the Fenton reaction and its continuous formation has an impact 
upon the brain’s neurovascular unit. 
According to the suggestions made in the previous research, we 
consider that, at least in some disorders, brain iron misregulation is 
the initial cause of neuronal death and that this misregulation might be 
the result of either genetic or non-genetic factors [7], and is considered 
to have autoimmune determinants [8]. Our previous research results 
suggest that methemoglobin plays a particularly important role as the 
carrier and donor of the cytotoxic and redox-active ferric (Fe3+) iron, 
and determines how iron is transported intracellularly (Figures 1-4).
Neuroscience has traditionally focused on the neurons of the 
central and peripheral nervous systems, and it is now becoming clear 
that neurons, glia and microvessels are organized into a well-structured 
neurovascular unit, while recent studies have highlighted the importance 
of brain endothelial cells in this modular organization [9]. Iron is 
essential for the normal cell function, but it also generates toxic Reactive 
Oxygen Species (ROS) that adversely affect vascular endothelium of the 
blood-brain barrier. The exposure of human neuroblastoma IMR-32 
cells to Ferric ammonium citrate (FAC) was investigated as a model 
of neuronal iron overload and neurodegeneration. The consequences 
of the exposure of cells to Ferric ammonium citrate showed that the 
exposure is associated to the increased oxidant cell levels, the activation 
of redox-sensitive signals, and apoptosis [10]. Leung G, Moody AR 
has demonstrated that ferric heme is significantly more pro-oxidant 
than the ferrous heme. In addition, they have shown that this ferric 
heme has a significantly higher relaxivity than its ferrous counterparts. 
In tandem, this evidence suggests that the MR imaging–detected T1 
(longitudinal relaxation time) high signal intensity within the vessel 
wall is an endogenous biomarker of an intraplaque environment that 
is highly pro-oxidant and proatherogenic. MR imaging measures 
showed a T1 relaxivity that was 10 times higher for ferric than for 
ferrous forms of hemoglobin. These results support the hypothesis that 
ferric methemoglobin-generated T1 high signal intensity reflects a pro-
oxidant environment that, in the setting of vessel wall disease, might be 
proatherogenic [11].
This justifies the study of the oxidant effect of methemoglobin 
catabolic products on vital organs and the CNS, resulting in their 
dysfunction. The research MRI data showed that extracellular 
methemoglobin generates significantly more lipid oxidation than 
the intracellular products; however, methemoglobin in both these 
environments has similar measures of r1 (longitudinal relaxivity 
of relaxation rate). Therefore, the T1 high signal intensity, due to 
methemoglobin, is not solely restricted to an environment that causes 
lipid oxidation. Thus, the ability of this high signal intensity to reflect 
Figure 1. The hemoglobin catabolism
Figure 2. The heme oxygenase
Figure 3. Focal positivity for feric iron binding in neurons showing patchy accumulations 
in brain of person died of Alzhimer disease in low magnification (x4HPF A and x10 HPF B).
A B
Figure 4. Free iron positivity in the cerebral parenchyma of a 77 year old patient with 
Alzheimer’s disease A) Focal distribution of positive glia and neurons; B) accumulation of 
strong iron-positive perivascular regions. Staining: Perl’s Prussian Blue reaction for ferric 
iron- Magnification 40x.
Source: Stifter Sanja, Department of Pathology, University of Rijeka School of Medicine.
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Discussion
On the basis of our observation, we point out the specific cellular 
methemoglobin and heme catabolism when the last product is the 
ferric iron which, together with cytotoxic and paramagnetic property, 
has a notable role “in-situ”. We suggest that ferric iron and ferric iron-
induced oxidative stress constitute a common mechanism involved in 
the development of neurodegeneration, and we also suggest the initial 
cause of neuronal death as a result of environmental toxic factors. The 
experiments showed that ferric and ferrous iron can enter cells via 
different pathways, however they do not indicate which pathway is 
dominant in humans [19].
Heme, the major functional form of iron, is synthesized in the 
mitochondria. Smith MA, et al. suggests that iron is able to participate 
oxidation in in-situ and it readily catalyzes an H2O2-dependent 
oxidation, and they indicate that iron accumulation could be an 
important contributor towards the oxidative damage of Alzheimer’s 
disease [20]. According to our point of view, our work supports the 
above statement about the importance of disturbed heme metabolism 
when the heme oxygenase-1, which is an enzyme that catalyzes the 
the plaque at risk may be diminished. However, it is known that in 
the absence of any chemical modifications, ferric heme substantially 
degrades the integrity of the RBC membrane, and the eventual fate of 
a static RBC is lysis. Thus, the intracellular methemoglobin is destined 
to rapidly become extracellular, thereby adding to the oxidative drive 
[12]. The cellular and intercellular iron transport mechanisms 
in the central nervous system (CNS) are still poorly understood, 
meanwhile the accumulating evidence suggests that impaired iron 
metabolism is the initial cause of neurodegeneration [13]. Brar S, 
et al. concluded that the development of Parkinsonism during the 
course of AD appears to be associated with the accumulation of iron, 
which in turn may contribute to the pathogenesis of neurologic 
decline [14] .
Results
Our results point out the consequence of the toxic environmental 
oxidants, caused by brain damage with a view to the role of 
methemoglobin catabolism in pregnancy as the source of ferric (Fe3+) 
iron form concentrated in various brain regions. Methemoglobin and 
hemolysis both occur as a result of oxidative stress, but the prevalent 
difference between them is that methemoglobin is a reversible 
phenomenon (oxidant–antioxidant balance) whereas hemolysis, which 
occurs as a result of oxidative stress on the erythrocyte membrane, is 
an irreversible event. Methemoglobinemia can additionally exacerbate 
an existing anemia, stimulating hypoxia that may be additionally 
dangerous. Our prospective study of methemoglobin in pregnancy 
revealed a significant rise the level of methemoglobin >1.5 g/L (r= 
0.72, p < 0.01) in the air-polluted exposure period, which can be 
explained on the basis of an oxidant–antioxidant imbalance, resulting 
in methemoglobinemia [15]. Methemoglobinemia and stillbirths 
recorded throughout exposure period are significantly higher than 
those recorded in the control period (p = 0.0205) and the frequencies 
of reproductive loss were significantly lower in the control than in the 
exposure period (p < 0.05) [16].
As we have found no evidence of the consequences of mother 
methemoglobinemia on the fetus, the second objective was to direct 
attention to methemoglobin as an early biomarker of the environmental 
toxic of oxidative stress effects, which puts pregnancy at risk and may 
later impair the health of newborns, children and adolescents. The 
conducted proper research found that neonatal jaundice incidence 
(p=0.034), heart murmur at a later age (p=0.011) and mild disorders in 
children and adults such as dyslalia and learning/memory impairments 
(p=0.002) were significantly higher than in children and adults of 
control mothers without pregnancy methemoglobinemia [17]. Lavezzi 
AM, Mohorovic L, et al. recently presented the findings confirmed by 
pathohistological technique that under the adverse conditions, ferric 
iron positivity in capillary endothelial cells of the blood-brain barrier in 
the fetus rises, also resulting in preterm birth, stillbirth or early neonatal 
death [18]. The application of the Blue Prussian method highlighted 
the accumulations of blue granulations, indicative for non-heme 
Fe3+ positive reactions, in the brainstem and cerebellum of 12 (33%) 
of the 36 victims, while there were none in the control group. In the 
positive cases, iron deposits were widespread in the brain parenchyma 
or localized in specific areas showing a variable extent and intensity 
(Figures 5 and 6)
Figure 5. Cerebellum-Ferric iron positivity in: A) subcortical region and B) parenchyma 
in the dentate nucleus area in a 6 month-old victim of SIDS (case no.9). In C) and D) 
equivalent ironnegative regions in an age-matched control case. Staining: Perls’ Prussian 
Blue reaction for ferric iron-Magnification A)C): 10x; B)D): 20×.
Source:Lavezzi AM, Mohorovic L Alfonsi G, Coma MF, Matturri L, Brain iron 
accumulation in unexplained fetal and infant death victims with smoker mothers. The 
possible involvement of maternal methemoglobinemia. Lino Rossi Research Center for 
the study and prevention of unexpected perinatal death and SIDS, Department of Surgical, 
Reconstructive and Diagnostic Sciences, University of Milan, Italy.
Figure 6. Blood-brain barrier vessels- A) Iron positivity in endothelial cells of a victim of 
SIUD aged 36 gestational weeks (case no.3). B) Iron negativity in an age-matched control 
case. Staining: Perls’ Prussian Blue reaction for ferric iron-Magnification A) B): 20×.
Source:Lavezzi AM, Mohorovic L Alfonsi G, Coma MF, Matturri L, Brain iron 
accumulation in unexplained fetal and infant death victims with smoker mothers.The 
possible involvement of maternal methemoglobinemia. Lino Rossi Research Center for 
the study and prevention of unexpected perinatal death and SIDS, Department of Surgical, 
Reconstructive and Diagnostic Sciences, University of Milan, Italy.
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conversion of methemoglobin and heme to ferric iron, is increased 
in Alzheimer’s disease, suggesting the increased heme turnover as 
a source of redox-active iron. Perry G, et al. have found that while 
mitochondrial DNA and cytochrome C oxidase activity are increased 
in Alzheimer’s disease, the number of mitochondria is decreased, 
indicating the accelerated mitochondria turnover and suggesting 
mitochondrial dysfunction as a potentially inseparable component 
of the initiation and progression of Alzheimer’s disease [21]. It was 
also discovered that oxidative damage occurs primarily within the 
cytoplasm rather than in mitochondria. This leads to the hypothesis 
that mitochondria, as a source, provide hydrogen peroxide, which, as 
an intermediate, once in the cytoplasm, will be converted into highly 
reactive hydroxyl radicals through Fenton reaction in the presence 
of metal ion and cause damage to the cytoplasm [22]. Cell apoptosis 
is initiated by extracellular and intracellular signaling pathways, the 
death receptor- and the mitochondria-mediated pathway.
Various pathologies can result from oxidative stress-induced 
apoptotic signaling, consequently leading to ROS increases and/or 
antioxidant decreases, the disruption of intracellular redox homeostasis, 
and irreversible oxidative modifications of lipid, protein, or DNA [23].
Furthermore, iron participates in diverse pathologic processes by 
way of the Fenton reaction, which catalyzes the formation of reactive 
oxygen species (ROS). To test the hypothesis that this reaction 
accelerates apoptosis, Jacob AK,et al used human umbilical vein 
endothelial cells (HUVECs) as surrogates for the microvasculature 
in vivo. HUVECs were loaded with Fe [III] (ferric chloride and 
ferric ammonium citrate) and executed apoptosis after a heat shock 
stimulus [24]. Brain iron is a major contributor to magnetic resonance 
imaging (MRI) contrast in the normal gray matter. Non-heme brain 
iron is present mainly in the form of ferritin. The quantitation of non-
heme brain ferric iron indicated by MRI helps in the diagnosis and 
monitoring of different neurological diseases [25]. Most of the brain’s 
non-heme iron is believed to be present as a storage pool consisting 
of ferritin or hemosiderin and also as a product of methemoglobin 
catabolism [26]. However, the concentration of transferrin–bound 
iron is always far too small to affect MRI. This fact suggests that the 
role of methemoglobin catabolism as the source of ferric iron (FeIII) 
form concentrated in various brain regions should be considered. 
Nowadays, non-heme-bound Fe3+ is quantified by using Magnetic 
Resonance Imaging (MRI), thanks to its paramagnetic properties. It 
is believed that most non-heme bound iron is deposited in the form of 
ferritin, hemosiderin, or methemoglobin catabolic products, whereas 
transferrin-bound iron concentration is always low and cannot be 
detected by MRI [27]. Recent research results indicate a ferrihydrite-
magnetite core-shell ferritin structure. It was also found that the 
magnetite in the ferritin iron core is not a source of free toxic ferrous 
iron, as it had been previously believed. Therefore, the presence of 
magnetite in the ferritin cores of patients with Alzheimer’s disease is not 
the cause of their increased brain ferrous iron (II) concentration [28].
Conclusion
Abundant in the source of cytotoxic and redox-active ferric (Fe3+) 
iron which without Ferrous- Ferric inversions, “in situ” as a cause 
of iron–induced cellular oxidative stress, have a direct and specific 
impact on the brain endothelial small vessels, and increase the rate 
of endothelial cell apoptosis and so make possible the accumulation 
of methemoglobin, heme and ferric iron, in brain parenchyma. In 
conclusion, we point out the importance of methemoglobinemia 
not only as the biomarker and precursor of environmental oxidants’ 
noticeable effects, but also as a carrier and donor of the redox-active 
ferric iron form. We identify ferric iron as the originator of the 
accumulation of brain parenchyma that has an important role in 
crossing the brain’s microvessels to the neurons (neurovascular unit 
damage), causing neuronal death, continuous ageing process, and 
finally leading to severe neurodegenerative disorders such as AD, 
PD, MS and other diseases. Nevertheless, as to the relation between 
environmental oxidants and the pathogenesis of neurodegenerative 
diseases, need further research.
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